Superoxide dismutase [Mn], mitochondrial (SOD2)

Superoxide dismutase [Mn], mitochondrial (SOD2) is a nuclear-encoded antioxidant enzyme that localizes to the mitochondrial matrix, where it serves as the primary defense against superoxide radicals generated by the electron transport chain (UniProt P04179). By converting highly reactive superoxide anions into less toxic hydrogen peroxide and oxygen, SOD2 maintains mitochondrial integrity and prevents oxidative damage to DNA, lipids, and proteins (PubMed: 21457640). In many pathological states, including cancer and chronic inflammation, the endogenous production of SOD2 is insufficient to manage the oxidative burden, leading to tissue injury and disease progression. Therapeutic MnSOD mimetics are small-molecule manganese complexes designed to replicate this enzymatic activity, providing a catalytic mechanism to reduce pathological levels of reactive oxygen species (ROS) (PubMed: 20846309). These agents are currently being investigated for their ability to protect normal tissues from radiation-induced damage, such as oral mucositis, and for their potential to selectively induce apoptosis in cancer cells by altering the intracellular redox environment (Galera Therapeutics; PubMed: 31557470). Consequently, SOD2-mimetic activity represents a significant pharmacological strategy for mitigating oxidative stress-mediated pathologies.

Other names

Manganese-dependent superoxide dismutaseMnSODSuperoxide dismutase 2IPR001189

MnSOD mimetics act as catalytic antioxidants that replicate the function of the endogenous SOD2 enzyme by facilitating the dismutation of superoxide anion radicals into hydrogen peroxide and molecular oxygen through a cyclic reduction-oxidation of a metal center (typically manganese).